a dose-dependent and often complete blockade of all three signs was obtained with l-dopa plus carbidopa ( 10:1 ) as well as with other classes of pharmacological agents that are used in the treatment of parkinson 's disease , i.e . direct or indirect dopamine ( da ) agonists ( amantadine , pergolide , lisuride ) and inhibitors of monoamine oxidase ( mao ) ( clorgyline , pargyline , deprenyl , tranylcypromine ) .
C0030567
parkinson 's disease
C0031007
pergolide